Publications by authors named "L M Gaster"

Claim this Profile
8
8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands.
Tom D Heightman, Laramie M Gaster, Sarah L Pardoe, Jean-Pierre Pilleux, Michael S Hadley

Bioorg Med Chem Lett· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3,4-Dihydro-2H-benzoxazinones are 5-HT(1A) receptor antagonists with potent 5-HT reuptake inhibitory activity.
Peter J Atkinson, Steven M Bromidge, Mark S Duxon, Laramie M Gaster, Michael S Hadley

Bioorg Med Chem Lett· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for a molecular mechanism of teratogenicity of SB-236057, a 5-HT1B receptor inverse agonist that alters axial formation.
Karen A Augustine-Rauch, Qin J Zhang, Jennifer L Leonard, Antony Chadderton, Michael J Welsh, Laramie Gaster

Birth Defects Res A Clin Mol Teratol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
N J Laping, E Grygielko, A Mathur, S Butter, J Bomberger, L Gaster

Mol Pharmacol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
Gareth J Inman, Francisco J Nicolás, James F Callahan, John D Harling, Laramie M Gaster

Mol Pharmacol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis